Skip to main content
. 2016 Jul 18;2016:2068691. doi: 10.1155/2016/2068691

Table 2.

Different results on various suPAR studies in FSGS and other glomerulopathies.

Negative results References Positive results References
Serum suPAR levels did not correlate to eGFR [9, 13] Serum suPAR levels were inversely correlated with eGFR [10, 1424]
Serum suPAR levels did not correlate to CRP levels [10, 13, 17] Serum suPAR levels were positively correlated with CRP levels [16, 18]
Serum suPAR levels are not influenced by immunosuppression [17, 18] Serum suPAR levels are influenced by immunosuppression [10, 93]
Serum suPAR levels are not influenced by subtypes of FSGS [11, 13, 89] Serum suPAR levels are influenced by subtypes of FSGS [12]
Urine suPAR levels are influenced by subtypes of FSGS [67]
Serum suPAR levels are not different between primary and secondary FSGS [12] Serum suPAR levels are higher in primary FSGS than in secondary FSGS [89]
Urine suPAR levels are higher in primary FSGS than in secondary FSGS [67]
Serum suPAR levels did not predict response to steroids [14, 18] High serum suPAR levels predicted better response to steroids [13]
High serum suPAR levels were not associated with acute tubulointerstitial lesions [13] High serum suPAR levels were associated with >50% interstitial fibrosis [12]

suPAR, soluble urokinase-type plasminogen activator receptor; FSGS, focal segmental glomerulosclerosis; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate.